Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to catch lung cancer early by boosting screening rates

NCT ID NCT06000683

Knowledge-focused Sponsor: University of California, Irvine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program to help more people at high risk for lung cancer get a low-dose CT scan, which can catch the disease early and save lives. The program included notifying doctors, educating patients, offering financial help, and reminding patients to talk about screening during their visit. 79 people aged 50-80 with a heavy smoking history took part. The goal was to see if these steps increased the number of screening orders and completed scans within six months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

79 people

The number who actually took part.

Started

Oct 2023

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Patients' Inclusion Criteria: 1. Aged 50- 80 years of age. 2. Be able to Speak English, Spanish, or Vietnamese 3. Must have a scheduled appointment with their Primary Care Providers within next one to three months. 4. The Scheduled PCP appointment is at any of the UCI Health primary care clinics in Orange County including two UCI federally qualified health centers 5. History of 20 pack year smoking history ( based on survey self report) 6. Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self report) Patients' Exclusion Criteria: 1. Prior history of lung cancer 2. chest CT for any reason in the last 12 months based on self-report and UCI EMR 3. history of Alzheimer's disease or dementia Providers' Inclusion Criteria: 1. Primary Care Providers whose patients were enrolled in the Empower LCS trial. 2. Received notifications about the eligibility of their patients for lung cancer screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer

Contacts and locations

Locations

  • UCI Health - Costa Mesa

    Costa Mesa, California, 92627, United States

  • UCI Health - Laguna Hills

    Laguna Hills, California, 92653, United States

  • UCI Health - Newport Beach MacArthur

    Newport Beach, California, 92660, United States

  • UCI Health - Tustin

    Tustin, California, 92670, United States

  • UCI Health Gottschalk Medical Plaza

    Irvine, California, 92697, United States

  • UCI Health-Yorba Linda

    Yorba Linda, California, 92886, United States

  • UCI Medical Center

    Orange, California, 92868, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.